ICECURE MEDICAL LTD CAESAREA ICCM
SHS NEW · Common Stock · CUSIP M53071136
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 10 |
| Q4 2022 | 12 |
| Q1 2023 | 10 |
| Q2 2023 | 13 |
| Q3 2023 | 13 |
| Q4 2023 | 18 |
| Q1 2024 | 13 |
| Q2 2024 | 15 |
| Q3 2024 | 16 |
| Q4 2024 | 14 |
| Q1 2025 | 15 |
| Q2 2025 | 19 |
| Q3 2025 | 17 |
| Q4 2025 | 19 |
| Q1 2026 | 18 |
| Q2 2026 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2024 | 4 | 5 |
| Q4 2024 | 4 | 7 |
| Q1 2025 | 5 | 5 |
| Q2 2025 | 10 | 2 |
| Q3 2025 | 9 | 4 |
| Q4 2025 | 7 | 6 |
| Q1 2026 | 9 | 6 |
| Q2 2026 | 0 | 18 |
Biggest buyers
| None |
Biggest sellers
| ARMISTICE CAPITAL, LLC | Sold out | -2.7m |
| UBS Group AG | Sold out | -154.2k |
| Concurrent Investment Advisors, LLC | Sold out | -78.3k |
| Warberg Asset Management LLC | Sold out | -65.6k |
| HRT FINANCIAL LP | Sold out | -47.6k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -40.5k |
| Hudson Bay Capital Management LP | Sold out | -30.0k |
| Gunderson Capital Management LLC | Sold out | -20.0k |
| MORGAN STANLEY | Sold out | -17.0k |
| Lloyd Advisory Services, LLC. | Sold out | -16.0k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
Haixiang Li
13D · may seek influence
+0.1 pts · filed 2026-03-27
Stated purposeThis item is not being amended by this Schedule 13D/A. Full filing |
45.8% |
Insider purchases and sales since 1 Apr 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported since 1 Apr 2026.
Holders, Q2 2026
| Manager | Shares | Change |
|---|